This inventor holds 2 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignee: Probiodrug Ag. Active years: 2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Halle/Saale, DE (2001)
- Dieskau, DE (2001)
Company Filing History:
Years Active: 2001
Title: Fred Rosche: Innovator in Diabetes Treatment
Introduction
Fred Rosche is a notable inventor based in Halle/Saale, Germany. He has made significant contributions to the field of diabetes treatment through his innovative patents. With a total of 2 patents, Rosche's work focuses on methods to manage blood sugar levels in mammals.
Latest Patents
Rosche's latest patents include a method for raising blood sugar levels in hypoglycemic mammals by administering inhibitors of dipeptidyl peptidase IV. This method aims to reduce the degradation of glucagon, thereby providing a therapeutic approach to managing hypoglycemia. Another patent involves the use of dipeptidyl peptidase IV effectors for lowering blood glucose levels in mammals. This novel therapeutic regimen enhances insulin release, which can help mitigate hyperglycemia associated with food intake.
Career Highlights
Fred Rosche is currently associated with Probiodrug, a company dedicated to developing innovative treatments for diabetes and related conditions. His work has been instrumental in advancing therapeutic options for patients suffering from blood sugar regulation issues.
Collaborations
Rosche has collaborated with notable colleagues such as Hans-Ulrich Demuth and Joem Schmidt, contributing to the development of effective diabetes treatments.
Conclusion
Fred Rosche's innovative patents and contributions to diabetes treatment highlight his role as a significant inventor in the medical field. His work continues to impact the management of blood sugar levels in mammals, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile